Aridis Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This SDG score for Aridis Pharmaceuticals Inc indicates the company's transparency towards the UN Sustainable Development Goals. Detailed ESG analysis of Aridis Pharmaceuticals Inc can be accessed by signing up for free. This article includes a questions and answers table about Aridis Pharmaceuticals Inc.
Aridis Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 8.0, social score of 6.4 and governance score of 8.0.
7.5
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 149 | Torrent Pharmaceuticals Ltd | 7.6 | High |
| 149 | Virbac SA | 7.6 | High |
| 160 | Aridis Pharmaceuticals Inc | 7.5 | High |
| 160 | C4X Discovery Holdings PLC | 7.5 | High |
| 160 | Ascentage Pharma Group International | 7.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aridis Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aridis Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aridis Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aridis Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Aridis Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aridis Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aridis Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-320 is a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin to treat infections caused by methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus; AR-105, a fully human IgG1 mAb, which is in Phase II trials to target gram-negative bacteria P. aeruginosa; AR-101, a human IgM mAb, which is in Phase IIa clinical trials for the treatment of hospital-acquired pneumonia (HAP)and ventilator-associated pneumonia (VAP) caused by P. aeruginosa serotype O11; AR-401 that is in preclinical stage to treat infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-501, an anti-infective therapy, which is in Phase I/IIa clinical trial to manage chronic lung infections in cystic fibrosis patients. In addition, it is developing AR-712 and AR-701, a cocktail of two fully human immunoglobulin 1, or IgG1, mAbs, which is in Phase I/II clinical for the treatment of mild to moderate non-hospitalized COVID-19 patients. Aridis Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Los Gatos, California.